Investing
Exclusive-Icahn poised to win at least one seat on Illumina’s board -sources
© Reuters. FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake
By Svea Herbst-Bayliss and Greg Roumeliotis
NEW YORK (Reuters) -Activist investor Carl Icahn is set to win enough Illumina Inc (NASDAQ:) shareholder support to install at least one of his three nominees to the gene sequencing machine maker’s board, two people familiar with the matter said on Wednesday.
A preliminary vote tally shows that Icahn nominee Andrew Teno has won enough shareholder support to get on Illumina’s board, the sources said.
The sources added that the tally has not been finalised and Illumina shareholders can change their votes until the company’s annual shareholder meeting starts on Thursday.
The sources asked not to be identified because the matter is confidential. Icahn and Illumina spokespeople did not immediately respond to requests for comment.
Icahn’s challenge against Illumina, whose market value of $33 billion makes it this year’s biggest board fight, offers the 87-year-old corporate raider a chance to reassert his investment acumen.
This month, he faced his own investor challenge after short seller Hindenburg Research issued a report saying his investment firm Icahn Enterprises LP artificially inflated its dividend yield and the value of its assets.
Icahn, who owns 1.4% of Illumina, put forward three director candidates, a move that could result in the ouster of Chief Executive Officer Francis deSouza and Chairman John Thompson from Illumina’s nine-member board.
The investor has accused Illumina’s board of poor oversight, especially with regards to the company’s $7.1 billion acquisition of cancer test maker Grail.
Illumina completed the deal despite opposition from U.S. and European antitrust regulators, who are now trying to force it to unwind it. Icahn has blamed the Grail deal for Illumina losing $50 billion in market value.
Earlier this month, proxy advisory firm Institutional Shareholder Services recommended Illumina shareholders back Teno, arguing he would be an adequate replacement for Thompson.
Two days earlier, proxy adviser Glass Lewis said Illumina shareholders should vote for two of Carl Icahn’s nominees to replace deSouza and Thompson.
Read the full article here
-
Make Money7 days ago
The 15 Fastest-Growing Jobs in America for the Coming Decade
-
Passive Income6 days ago
This Minimalist Lamp Lets You Pick From 16 Million+ Lighting Colors for Maximum Productivity
-
Side Hustles6 days ago
Protect Your Business With AdGuard VPN’s Powerful Security Features
-
Side Hustles7 days ago
Meta Tests Custom AI Images on Facebook, Instagram Feeds
-
Passive Income7 days ago
Tired of Getting Work Calls After Hours? Try This.
-
Make Money5 days ago
15 Jobs That Will Shrink the Fastest Over the Next Decade
-
Side Hustles7 days ago
Proto Hologram Boxes Project 3D Images, Like ‘The Jetsons’
-
Side Hustles4 days ago
3 Steps You Can’t Miss When Growing Your Business